Corporate Profile

At SOPHiA GENETICS, we are bringing the power of data and artificial intelligence to healthcare. Our AI platform analyzes multimodal data - including genomics, radiomics, clinical, biological, and digital pathology data - to generate actionable insights for patients with cancer or rare diseases.

Today, over 770 healthcare institutions use our cloud-native, consumption-based SaaS platform to bring the power of data-driven medicine to millions of patients across the globe. Beyond the clinical market, our platform is used by BioPharma partners for AI-powered drug discovery, development, and deployment.

Investor Events
TD Cowen’s 9th Annual FutureHealth Conference
Tuesday, September 10, 2024
3:15pm - 4:00pm EDT
Morgan Stanley’s 22nd Annual Global Healthcare Conference
Wednesday, September 4, 2024
1:50pm - 2:25pm EDT
SOPHiA GENETICS Second Quarter 2024 Earnings Conference Call
Tuesday, August 6, 2024
8:00am - 9:00am EDT

View all events

Press Releases
Sep 14, 2024
SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024

Research highlights the use of multimodal machine learning to identify non-small cell lung cancer patients predicted to derive the most benefit from combination immunotherapy BOSTON and ROLLE,...

Sep 12, 2024
SOPHiA GENETICS Announces Poster Presentations at ESMO 2024

Research presented will include the applications of new diagnostic tools and machine learning multimodal signatures in clinical trials BOSTON and ROLLE, Switzerland, Sept. 12, 2024 /PRNewswire/ --...

Sep 12, 2024
SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024

The global collective intelligence network aims to accelerate precision oncology research and care BOSTON and ROLLE, Switzerland, Sept. 12, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a...

View all releases

Stock Information

View current and historic stock prices, analyst information, and more

Financial Information

Download quarterly earnings reports, supplementary data, SEC filings, and more

Corporate Governance

Learn about our governance guidelines, code of ethics, Board of Directors, and more

Email Alerts
To opt-in for investor email alerts, please enter your email address. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.
* Required Fields
Contact Us

General Inquiries

SOPHiA GENETICS
La Pièce 12, CH-1180
Rolle, Switzerland
+41 21 694 10 60

ir@sophiagenetics.com

Transfer Agent

Computershare Trust Company, N.A.
Courier Delivery:
P.O. Box 43006
Providence RI 02940-3006
Overnight Delivery:
150 Royall St. STE 101
Canton, MA 02021

877.373.6374
www.computershare.com